Measles in the vaccinated host

被引:0
作者
Stout, Rebecca [1 ,2 ]
Muir, David [3 ]
Sriskandan, Shiranee [1 ,2 ]
机构
[1] Imperial Coll London, Dept Infect Dis, London, England
[2] Imperial Coll London Hosp, St Marys Hosp, Infect Dis, London, England
[3] Charing Cross Hosp, Virol Infect & Immun Dept, Northwest London Pathol, London, England
关键词
infectious diseases; immunology; vaccination/immunisation; nosocomial infections; systemic lupus erythematosus; IGG AVIDITY; OUTBREAK; ELIMINATION; IMMUNITY;
D O I
10.1136/bcr-2023-259429
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A woman in her 40s known to have systemic lupus erythematosus presented with a maculopapular rash on her face, neck and chest following measles exposure. She had received a single-dose measles vaccine as a child in the 1970s and was therefore presumed to be immune, and thus not infectious. As a result, she was initially managed in an open bay. Measles virus IgM antibody in serum was undetectable; however, measles virus RNA was subsequently detected in throat swab by PCR, which is consistent with current infection. Measles is one of the most transmissible diseases in the world and cases are rising both in the UK and globally. Our case and literature review highlight the risk of vaccine failure in measles, especially in people who have not received two doses of the measles, mumps and rubella vaccine. It also highlights the challenges in diagnosing measles in previously vaccinated individuals.
引用
收藏
页数:4
相关论文
共 34 条
  • [1] The Reemergence of Measles
    Abad, C. L.
    Safdar, N.
    [J]. CURRENT INFECTIOUS DISEASE REPORTS, 2015, 17 (12)
  • [2] Vaccines for measles, mumps, rubella, and varicella in children
    Di Pietrantonj, Carlo
    Rivetti, Alessandro
    Marchione, Pasquale
    Debalini, Maria Grazia
    Demicheli, Vittorio
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (04):
  • [3] Dunn JJ, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104430
  • [4] European Centre for Disease Prevention and Control, 2022, Poland: recommended Vaccinations [ECD]
  • [5] Breakthrough Infections: A Challenge towards Measles Elimination?
    Fappani, Clara
    Gori, Maria
    Canuti, Marta
    Terraneo, Mara
    Colzani, Daniela
    Tanzi, Elisabetta
    Amendola, Antonella
    Bianchi, Silvia
    [J]. MICROORGANISMS, 2022, 10 (08)
  • [6] Measles immunity and immunosuppression
    Griffin, Diane E.
    [J]. CURRENT OPINION IN VIROLOGY, 2021, 46 : 9 - 14
  • [7] Challenges of measles and rubella laboratory diagnostic in the era of elimination
    Hubschen, J. M.
    Bork, S. M.
    Brown, K. E.
    Mankertz, A.
    Santibanez, S.
    Ben Mamou, M.
    Mulders, M. N.
    Muller, C. P.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2017, 23 (08) : 511 - 515
  • [8] Measles
    Hubschen, Judith M.
    Gouandjika-Vasilache, Ionela
    Dina, Julia
    [J]. LANCET, 2022, 399 (10325) : 678 - 690
  • [9] Measles is now "an imminent threat" globally, WHO and CDC warn
    Iacobucci, Gareth
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2022, 379 : o2844
  • [10] The epidemiology of measles in Poland: prevalence of measles virus antibodies in the population
    Janaszek, W
    Gut, W
    Gay, NJ
    [J]. EPIDEMIOLOGY AND INFECTION, 2000, 125 (02) : 385 - 392